Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.95B | 1.82B | 1.86B | 1.81B | 1.86B | Gross Profit |
1.66B | 754.10M | 884.30M | 874.30M | 908.40M | EBIT |
480.20M | 441.40M | 641.50M | 641.00M | 688.00M | EBITDA |
992.70M | 1.18B | 1.19B | 1.16B | 1.06B | Net Income Common Stockholders |
126.90M | 204.90M | -56.80M | 453.40M | 106.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.40B | 340.40M | 240.90M | 744.10M | 528.10M | Total Assets |
15.65B | 14.53B | 14.44B | 14.18B | 14.04B | Total Debt |
10.00B | 8.44B | 7.98B | 8.45B | 8.36B | Net Debt |
8.60B | 8.43B | 7.74B | 7.71B | 7.83B | Total Liabilities |
13.60B | 12.02B | 11.48B | 11.15B | 11.08B | Stockholders Equity |
2.06B | 2.51B | 2.96B | 3.03B | 2.96B |
Cash Flow | Free Cash Flow | |||
-19.00M | 93.50M | 305.90M | 221.80M | 135.20M | Operating Cash Flow |
745.10M | 787.50M | 934.40M | 865.80M | 815.20M | Investing Cash Flow |
-731.40M | -593.40M | -639.70M | -555.70M | -598.80M | Financing Cash Flow |
1.04B | -85.00M | -809.70M | -89.70M | -27.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £7.84B | 6.15 | 32.10% | 2.62% | -24.74% | -63.34% | |
71 Outperform | £8.02B | 34.37 | 17.17% | 4.45% | 5.38% | 86.34% | |
71 Outperform | £18.82B | 9.57 | 21.94% | 3.62% | -13.09% | 231.40% | |
67 Neutral | £52.54B | 24.72 | 5.28% | 5.21% | -6.68% | -77.57% | |
64 Neutral | £7.54B | 66.60 | 5.50% | 4.57% | 8.61% | ― | |
63 Neutral | $8.48B | 10.79 | 5.35% | 4.36% | 3.55% | -11.17% | |
56 Neutral | £2.39B | ― | -4.09% | 6.99% | 20.25% | -128.71% |